The company Health-E Commerce — the parent brand of FSA Store and HSA Store, the first and leading online stores dedicated exclusively to products and services that qualify for Flexible Spending Accounts (FSA) and Health Savings Accounts (HSA) — has announced an expansion of its selection of trusted weight loss medications.
Shoppers on the FSA Store® and HSA Store® platforms now have access to a broader range of weight management solutions that meet FSA and HSA eligibility requirements, making the process of purchasing these products more convenient and accessible.
New prescription weight loss options from MEDVi and Remedy Meds, operating through Forbes Health, are now available on FSA Store and HSA Store, expanding the Health-E Commerce portfolio alongside solutions from Shed and LifeMD. Each of these telemedicine platforms provides personalized support and access to prescription weight loss medications for eligible patients, reflecting the broader transformation of the medical weight loss market in 2026.
During this period, telemedicine platforms, including MEDVi and Remedy Meds, have emerged as key players in expanding access to modern GLP-1 medications, focusing on compounded versions of semaglutide (the active ingredient in Wegovy and Ozempic) and tirzepatide (Mounjaro and Zepbound), helping to partially address the challenges of high costs and limited availability of branded medications.
By adding partners like MEDVi and Remedy Meds, Health-E Commerce is moving beyond OTC products into: GLP-1 weight loss medications, Telehealth consultations, and Personalized treatment programs.
Below is a current overview of offerings, pricing, and key features for both services as of April 2026.
MEDVi: High-Tech Flexibility
MEDVi has positioned itself as a streamlined, “technology-first” platform. In 2026, it is particularly noted for offering oral tablet options alongside traditional injections, catering to those with needle phobia.
- Medications Offered: Compounded semaglutide and tirzepatide (available as once-weekly injections or daily dissolvable tablets).
- Pricing (Introductory Rate): Often starts as low as $179 for the first month.
- Standard Monthly Rate: Roughly $299/month for semaglutide and higher for tirzepatide.
- Key “New” Features:
- Daily Oral Tablets: A major 2026 trend; MEDVi offers dissolvable semaglutide tablets for approximately $249/month.
- Fast-Track Shipping: They claim delivery within 24–48 hours of physician approval.
- No Long-Term Contracts: Operates on a month-to-month basis with a straightforward cancellation policy.
Remedy Meds: Comprehensive Clinical Support
Remedy Meds emphasizes a “concierge” experience. They were recently rated highly in early 2026 for their ease of onboarding and “all-inclusive” membership model.
With a special offer for new clients, you can get a $120 discount on your first month of treatment. This is the perfect way to test the effectiveness of the program without a large initial outlay.
- Medications Offered: Compounded semaglutide and tirzepatide. They also facilitate brand-name prescriptions (Ozempic/Zepbound) for those whose insurance covers them or who are willing to pay the $1,200+ out-of-pocket retail price.
- Pricing:
- Compounded Semaglutide: $299/month (flat fee, includes medication and support).
- Compounded Tirzepatide: $399/month.
- Key “New” Features:
- Unlimited Messaging: 24/7 access to clinical teams for side-effect management and dose titration.
- Holistic Integration: Their 2026 program now includes more robust “lifestyle determinants” support, such as personalized nutrition and sleep guidance within their app.
Comparison At-A-Glance
| Feature | MEDVi | Remedy Meds |
|---|---|---|
| Starting Price | ~$179 (Intro Offer) | $299 (Flat Fee) |
| Oral Options | Yes (Dissolvable tablets) | Primarily Injections |
| Support Level | Automated/On-demand | Continuous/Concierge |
| Availability | 49 States | Nationwide (U.S.) |
| Insurance | No (Cash only) | No (Cash only for compounds) |
What’s New in the 2026 Weight Loss Market?
Beyond these two specific platforms, the broader weight loss industry has hit several milestones this year:
- The “Wegovy Pill”: The FDA approved high-dose oral semaglutide (25mg and 50mg) earlier this year. While the brand-name pill is expensive, it has prompted telehealth providers like MEDVi to expand their compounded oral offerings.
- Medicare Shifts: As of 2026, some Medicare plans have begun covering GLP-1s for weight loss (specifically for patients with underlying heart conditions), though most telehealth platforms still operate on a cash-pay basis for compounded versions.
- Higher Dosages: A new 7.2mg semaglutide injection has entered the market, providing a higher ceiling for patients who plateued on the standard 2.4mg (Wegovy) dose.
Through telehealth integrations, users can access treatments like: semaglutide and tirzepatide
Highlight: Lowering barriers (cost, availability, logistics) for modern weight loss care.
Note: Compounded medications are not “FDA-approved” in the same way brand-name drugs are, as they are custom-mixed by pharmacies. However, they are legally permitted under federal law when the brand-name drug is on the FDA’s “shortage list.”
About Health-E Commerce
Health-E Commerce is the company behind FSA Store and HSA Store — two of the most recognized online destinations for FSA-eligible and HSA-eligible products in the United States. Together, these platforms serve more than 70 million consumers who use tax-advantaged healthcare accounts to manage everyday wellness expenses.
In addition to its retail platforms, Health-E Commerce launched Caring Mill, a private-label health and wellness brand designed to make essential products more accessible. A portion of every Caring Mill purchase supports the Children’s Health Fund, helping expand access to healthcare for children in underserved communities.
Health-E Commerce stands out for turning FSA and HSA funds into a seamless, modern healthcare shopping experience — now expanded to include telehealth and prescription weight loss solutions.
Since 2010, Health-E Commerce has focused on simplifying how consumers shop for qualified medical expenses online. The company also actively supports the expansion of FSA/HSA eligibility, including newer categories such as telehealth services and digital health solutions.
About Forbes Health
Forbes Health is a widely recognized platform for evidence-based health information, product reviews, and expert guidance. It helps consumers compare services, understand treatment options, and make more informed healthcare decisions.
With a strong focus on transparency and editorial independence, Forbes Health connects readers with medically reviewed content and practical tools designed to support long-term wellness.
Disclaimer (Weight Loss & Telehealth)
Prescription weight loss medications, including GLP-1-based treatments, may be eligible for reimbursement through FSA or HSA accounts. Coverage depends on your specific plan, so it is important to confirm details directly with your provider or plan administrator.
Some non-prescription weight loss programs may require a Letter of Medical Necessity to qualify for reimbursement.
This page may include affiliate links. If you choose to purchase through these links, Health-E Commerce and Forbes Health may receive a commission at no additional cost to you.
Results from weight loss programs and medications vary based on individual factors. Always consult a licensed healthcare professional before starting any new treatment or program.
